Friday, Vasogen Inc. (VSGN, VAS.TO) announced that Eldon Smith would succeed Terrance Gregg as chairman of its board pursuant to the retirement of Gregg. Gregg's resignation from Vasogen's board is due to the requirements of his role as president and chief executive officer of DexCom, Inc.
Smith, a Vasogen board member since 1998, is professor emeritus at the University of Calgary, Alberta, where he served as the Dean of the Faculty of Medicine subsequent to being Head of the Department of Medicine and the Division of Cardiology.
For comments and feedback: editorial@rttnews.com